Thorac Cardiovasc Surg 1979; 27(3): 187-189
DOI: 10.1055/s-0028-1096241
Copyright © 1979 by Georg Thieme Verlag Stuttgart

Heart Valve Replacement with the St. Jude Medical Prosthesis — First Clinical Results —

F. W. Hehrlein, M. G. Gottwik, M. Schlepper, G. Fraedrich
  • Department of Cardiovascular Surgery, Justus-Liebig-University, Giessen, and Kerckhoff-Clinic, Bad Nauheim
Further Information

Publication History

Publication Date:
11 December 2008 (online)

Summary

Starting in February 1978 52 St. Jude Medical Prostheses have been implanted in 47 patients (age 13–73 years) in aortic, mitral and tricuspid positions. Perioperative death occurred in 3 cases. Post mortem examination of these patients showed unimpaired valvular function. There were no other complications in an accumulated total valve time of approximately 300 months. Prior to surgery and post-operatively, several hemolytic parameters were analyzed. There was only a mild elevation in Serum LDH (285 ± 10 iV/L). Fifteen patients underwent recatheterization 3 months postoperatively. The mitral valves did not reveal an enddiastolic gradient at rest, while the aortic valves had a peak to peak gradient of 8 ± 2.1 mmHg. A standardized stress consisting of an infusion of isoproterenol was used. The results were compared to results obtained in patients with Björk-Shiley prostheses under identical conditions and did not show a significant difference. The preliminary hemodynamic findings correlate with preceding in vitro results and preclinical data, and the first clinical experience is promising.